DIN 02240863 — RELENZA 5 MG
RELENZA is a powder of Zanamivir marketed by GLAXOSMITHKLINE INC. The full Zanamivir monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02240863
- Brand name
- RELENZA
- Active ingredient
- Zanamivir
- Strength
- 5 MG
- Dosage form
- POWDER
- Route
- INHALATION; ORAL
- Manufacturer
- GLAXOSMITHKLINE INC
- Health Canada status
- MARKETED
- Drug class
- Neuraminidase inhibitor (antiviral agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.